Basic Search
|
Geographic Searches
|
Advanced Search |
MegadealsSubsidy Tracker: Industry Summary Page
Major Industry: pharmaceuticals
Subsidy Total: $3,972,211,621
Number of Awards: 2,783
Time Period: Earliest year of data: 1975. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this industry are for the period since 2012.
Notes: The dollar total above adjusts for the fact that there is an overlap between the amounts in one or more Megadeal entries and those of one or more of the other entries. The total includes only those entries matched to a parent company. The industry designation is the primary one for the parent's operations overall. Dollar totals do not include awards for which no subsidy value is disclosed.
Top 10 Parent Companies | Total Subsidy $ | Number of Awards |
Eli Lilly | $601,741,368 | 77 |
Regeneron Pharmaceuticals | $469,433,071 | 112 |
AstraZeneca | $436,175,713 | 52 |
Pfizer | $332,313,011 | 206 |
Novo Holdings A/S | $241,475,902 | 102 |
Elanco Animal Health | $189,545,200 | 7 |
Merck | $153,889,367 | 82 |
AbbVie | $145,729,008 | 68 |
Johnson & Johnson | $111,279,431 | 124 |
Bristol-Myers Squibb | $110,616,473 | 81 |
Individual Subsidy Records:
Warning: Attempt to read property "post_title" on string in
/usr/home/goodjobsfirst/public_html/subsidytrackerlive/function.php on line
2057
Warning: Attempt to read property "post_name" on string in
/usr/home/goodjobsfirst/public_html/subsidytrackerlive/function.php on line
2059
Company | Parent | Location | Subsidy Source | Year | Subsidy Value | Loan/Bailout Value | Type of Subsidy |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2006 | $113,958 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2006 | $64,881 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2006 | $25,410 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2007 | $425,295 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2007 | $88,277 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2007 | $63,676 | | tax credit/rebate |
ICOS CORPORATION | Eli Lilly | Washington | state | 2007 | $36,309 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2007 | $30,831 | | tax credit/rebate |
MEDICIS TECHNOLOGIES CORPORATION | Bausch Health | Washington | state | 2008 | undisclosed | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2008 | $239,698 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2008 | $120,165 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2008 | $71,546 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2008 | $36,174 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2009 | $543,597 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2009 | $127,860 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2009 | $66,838 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2009 | $56,100 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2009 | $53,997 | | tax credit/rebate |
PROFIBRIX INC | Novartis | Washington | state | 2009 | $16,522 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2010 | $131,488 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2010 | $105,430 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2010 | $95,385 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2010 | $72,840 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2010 | $56,975 | | tax credit/rebate |
PROFIBRIX INC | Novartis | Washington | state | 2010 | $23,490 | | tax credit/rebate |
ONCOTHYREON INC | Seattle Genetics Inc. | Washington | state | 2010 | $8,801 | | tax credit/rebate |
ONCOTHYREON INC | Seattle Genetics Inc. | Washington | state | 2011 | $2,611 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2011 | $3,872 | | tax credit/rebate |
AXIS SHIELD DIAGNOSTICS LIMITED | Abbott Laboratories | Washington | state | 2011 | $4,930 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2011 | $12,368 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2011 | $18,072 | | tax credit/rebate |
PROFIBRIX INC | Novartis | Washington | state | 2011 | $28,045 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2011 | $60,285 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2011 | $83,248 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2011 | $181,239 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2011 | $207,108 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2011 | $11,724 | | tax credit/rebate |
ONCOTHYREON INC | Seattle Genetics Inc. | Washington | state | 2011 | $19,669 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2011 | $33,727 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2011 | $42,682 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2011 | $51,253 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2011 | $91,754 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2011 | $106,749 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2011 | $143,394 | | tax credit/rebate |
IMMUNEX CORPORATION | Amgen | Washington | state | 2011 | $3,568,422 | | tax credit/rebate |
GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICA | GlaxoSmithKline | Washington | state | 2004 | $253,000 | | tax credit/rebate |
I C O S CORP | Eli Lilly | Washington | state | 2004 | $22,005 | | tax credit/rebate |
IMMUNEX CORPORATION | Amgen | Washington | state | 2004 | $581,065 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2004 | $40,481 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2004 | $481,822 | | tax credit/rebate |
IMMUNEX CORPORATION | Amgen | Washington | state | 2005 | $581,065 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2005 | $375,100 | | tax credit/rebate |
GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICA | GlaxoSmithKline | Washington | state | 2006 | $397,686 | | tax credit/rebate |
ICOS CORPORATION | Eli Lilly | Washington | state | 2006 | $72,042 | | tax credit/rebate |
IMMUNEX CORPORATION | Amgen | Washington | state | 2006 | $485,991 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2006 | $68,653 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2006 | $156,516 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2006 | $380,245 | | tax credit/rebate |
GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICA | GlaxoSmithKline | Washington | state | 2007 | $116,504 | | tax credit/rebate |
ICOS CORPORATION | Eli Lilly | Washington | state | 2007 | $1,375 | | tax credit/rebate |
IMMUNEX CORPORATION | Amgen | Washington | state | 2007 | $3,626,627 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2007 | $518,618 | | tax credit/rebate |
MEDICIS TECHNOLOGIES CORPORATION | Bausch Health | Washington | state | 2008 | $10,777 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2008 | $25,745 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2008 | $156,516 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2008 | $474,786 | | tax credit/rebate |
IMMUNEX CORPORATION | Amgen | Washington | state | 2008 | $3,658,748 | | tax credit/rebate |
MEDICIS TECHNOLOGIES CORPORATION | Bausch Health | Washington | state | 2009 | $10,777 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2009 | $25,745 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2009 | $99,581 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2009 | $156,516 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2009 | $351,337 | | tax credit/rebate |
IMMUNEX CORPORATION | Amgen | Washington | state | 2009 | $3,626,627 | | tax credit/rebate |
MEDICIS TECHNOLOGIES CORPORATION | Bausch Health | Washington | state | 2010 | $10,777 | | tax credit/rebate |
ONCOTHYREON INC | Seattle Genetics Inc. | Washington | state | 2010 | $19,669 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2010 | $25,745 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2010 | $51,253 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2010 | $91,754 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2010 | $99,581 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2010 | $143,394 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2010 | $298,738 | | tax credit/rebate |
IMMUNEX CORPORATION | Amgen | Washington | state | 2010 | $3,568,422 | | tax credit/rebate |
SANOFI AVENTIS US LLC | Sanofi | Washington | state | 2012 | $70,422 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2012 | $41,418 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2012 | $47,245 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2012 | $108,730 | | tax credit/rebate |
IMMUNE DESIGN CORP | Merck | Washington | state | 2012 | $4,408 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2012 | $219,157 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2012 | $19,023 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2012 | $19,311 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2012 | $106,749 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2012 | $101,569 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2012 | $11,724 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2012 | $53,148 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2012 | $44,191 | | tax credit/rebate |
ONCOTHYREON INC | Seattle Genetics Inc. | Washington | state | 2012 | $19,669 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2012 | $13,467 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2012 | $102,839 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2013 | $1,441 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2013 | $3,605 | | tax credit/rebate |
IMMUNE DESIGN CORP | Merck | Washington | state | 2013 | $4,304 | | tax credit/rebate |